Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany Update▲ PositiveResults24 Jul 2026

Dr. Lal PathLabs Ltd

Attached

Dr. Lal PathLabs Ltd has announced its Q1 FY27 financial results, with revenue increasing by 19.1% to Rs 798 Cr, EBITDA increasing by 28.7% to Rs 247 Cr, and PAT increasing by 27.2% to Rs 170 Cr. The company has also declared an interim dividend of 50% and has made two acquisitions in Ghana and India.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults24 Jul 2026

Greenply Industries Ltd

Please find Press Release of Greenply Industries Limited in respect of unaudited financial results of Q1 FY27.

Greenply Industries Ltd has announced its unaudited financial results for Q1 FY27, with a 20.7% YoY increase in consolidated revenue to Rs 724.9 crs, and a 27.1% YoY increase in Core EBITDA to Rs 78.3 crs. The company's Plywood business volume grew by 13.8% YoY, while MDF business volume grew by 24.7% YoY.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults24 Jul 2026

V-Mart Retail Ltd

Press Release_Q1FY27

V-Mart Retail Ltd reported a 23% year-on-year growth in revenue and 41% growth in PAT for Q1 FY'27, driven by strong operational performance and profitability.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults24 Jul 2026

Dr. Lal PathLabs Ltd

Attached

Dr. Lal PathLabs Ltd has announced its un-audited financial results for the quarter ended June 30, 2026, along with the declaration of an interim dividend of INR 5 per equity share. The company has also approved the acquisition of stakes in Sunshine Healthcare Limited and Neuome Technologies Private Limited through its subsidiaries.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults24 Jul 2026

Dr. Lal PathLabs Ltd

Attached

Dr. Lal PathLabs Ltd has announced its un-audited financial results for the quarter ended June 30, 2026, and approved the declaration of an interim dividend of INR 5 per equity share. The company has also granted stock options to eligible employees and approved the acquisition of stakes in Sunshine Healthcare Limited and Neuome Technologies Private Limited.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults24 Jul 2026

Dr. Lal PathLabs Ltd

Attached

Dr. Lal PathLabs Ltd has announced its un-audited financial results for the quarter ended June 30, 2026, and has approved the declaration of an interim dividend of INR 5 per equity share. The company has also approved the granting of stock options under its Employee Restricted Stock Unit Plan 2025 to eligible employees. Additionally, the company's Board of Directors has taken note of the acquisition of stakes in Sunshine Healthcare Limited and Neuome Technologies Private Limited by its subsidiaries.

Read more →📎 1 attachment
BSEResult▲ PositiveResults24 Jul 2026

Ponni Sugars (Erode) Ltd

Unaudited Financial Results for the quarter ended 30th June 2026

Ponni Sugars (Erode) Ltd has announced its unaudited financial results for the quarter ended 30th June 2026, showing revenue from operations at ₹9,187 crore, a 3.5% increase from ₹8,954 crore in the same quarter last year. The company's net profit for the quarter stood at ₹2,685 crore, a 46% increase from ₹1,835 crore in the same quarter last year.

Read more →📎 1 attachment
BSEResult▲ PositiveResults24 Jul 2026

Dr. Lal PathLabs Ltd

Attached

Dr. Lal PathLabs Ltd has announced its un-audited financial results for the quarter ended June 30, 2026, with the Board of Directors approving the same. The company has also declared an interim dividend of INR 5 per equity share, and has granted stock options to eligible employees. Additionally, the company's wholly owned subsidiaries have approved the acquisition of stakes in Sunshine Healthcare Limited and Neuome Technologies Private Limited.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults24 Jul 2026

Dalmia Bharat Ltd

Press Release on Unaudited Financial Results for the quarter ended June 30, 2026

Dalmia Bharat Ltd reported its unaudited financial results for the quarter ended June 30, 2026, with a 9% YoY increase in sales volume and 7% YoY increase in revenue from operations. The company's EBITDA per ton improved sequentially to Rs 1,055, and EBITDA stood at Rs 805 Cr. The company also completed the acquisition of Jaiprakash Associates' cement undertaking, adding 5.2 MnTPA of cement capacity and 3.3 MnTPA of clinker capacity.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults24 Jul 2026

Apar Industries Ltd

Earnings Call Update for Q1FY27

Apar Industries Ltd has reported Q1 FY27 earnings, with revenue up 29.1% YoY and 0.2% QoQ, driven by domestic revenue growth. EBITDA margin improved to 12.4%, and net profit surged 77.7% YoY and 84.2% QoQ. The company's Conductor Division reported 19.9% YoY revenue growth, while the Oil Division saw 34.7% YoY revenue growth.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults24 Jul 2026

Rama Phosphates Ltd

Outcome of Board meeting held on 24/07/2026

Rama Phosphates Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a profit from operations before exceptional items and extra ordinary items of ₹ 2,281.23 lakhs and net profit after tax of ₹ 1,706.44 lakhs.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults24 Jul 2026

Acutaas Chemicals Ltd

Investor Presentation on financial results for the first quarter ended June 30, 2026 is attached.

Acutaas Chemicals Ltd has released its Q1 FY27 financial results, showing a 59.1% YoY growth in revenue to ₹3,297 mn, driven by strong performance in its CDMO and advanced intermediates business. The company has also been certified as a Great Place to Work and received the Responsible Care certification from the Indian Chemical Council.

Read more →📎 1 attachment
← PreviousPage 440 of 479Next →